Precision medicine is a rapidly growing approach to disease prevention and treatment. The MEA precision medicine market is rapidly evolving, with rising use of gene therapy across the region, as well as the use of big data analytics and advanced technologies in precision medicine to improve the prevention and treatment of chronic illnesses, uncommon diseases, and even cancer. This new frontier of combining digital data and gene therapy is paving the door for new healthcare R&D, with a MEA market share of USD 4 4 billion estimated for 2022. With the use of artificial intelligence, the United Arab Emirates hopes to be the first country in the world to have the genetic sequencing of its entire population.
